A Proposed Preventive Role for Gamma-Hydroxybutyrate (XyremR) in Alzheimer’s Disease

Alzheimer's Research and Therapy - United Kingdom
doi 10.1186/s13195-016-0205-y
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Gamma-Hydroxybutyrate for Sedation in Children - Authors' Reply

Jornal de Pediatria
Child HealthPediatricsPerinatology
2007English

Gamma-Hydroxybutyrate (GHB) Withdrawal in Jamaica – A Case Report

WIMJ Open
2015English

The Role of KLF4 in Alzheimer’s Disease

Frontiers in Cellular Neuroscience
Molecular NeuroscienceCellular
2018English

The Role of APP in Alzheimer’s Disease

Advances in Alzheimer's Disease
2013English

Gamma-Hydroxybutyrate Overdose and Coma: A Case Report

Canadian Journal of Emergency Medicine
Emergency Medicine
2000English

Gamma-Hydroxybutyrate Treatment of Schizophrenia: A Pilot Study

Pharmacopsychiatry
MedicinePsychiatryMental HealthPharmacology
1981English

Pharmacist’s Role in Pharmacotherapeutic Management of Alzheimer’s Disease

Journal of Pharmacy of Istanbul University
PharmacyPharmaceutical Science
2017English

The Role of Genetics in Advancing Precision Medicine for Alzheimer’s Disease—A Narrative Review

Frontiers in Medicine
Medicine
2018English

Optogenetic Gamma Stimulation Rescues Memory Impairments in an Alzheimer’s Disease Mouse Model

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy